Safety of intra-arterial (IA) chemotherapy and blood brain barrier disruption (BBBD) for treatment of patients with malignant brain tumors
Tabb, John; Ambady, Prakash; Neuwelt, Edward; Uluc, Kutluay
2020

Files

Abstract

Administration of chemotherapy via intra-arterial (IA) route results in a higher concentration of targeted chemotherapy against resilient brain malignancies with a decreased systemic chemotherapy side effect. Osmotic blood-brain barrier disruption (BBBD) further intensify drug delivery and effects on brain malignancies. The aim of this study is to determine the safety of the use of intra-arterial chemotherapy and blood brain barrier disruption to treat malignant brain tumors.

Details

Title Safety of intra-arterial (IA) chemotherapy and blood brain barrier disruption (BBBD) for treatment of patients with malignant brain tumors
Creator Tabb, John : Oregon Health and Science University
Ambady, Prakash : Oregon Health and Science University
Neuwelt, Edward : Oregon Health and Science University
Uluc, Kutluay : Oregon Health and Science University
Meeting Name Research Week, Oregon Health and Science University, 2022
Publisher Oregon Health and Science University
Date 2020
Subjects
Keywords
DOI https://doi.org/10.6083/cv43nx55c
Content Type Abstract
Department Division of Hematology and Medical Oncology
School School of Medicine
Copyright Status
In copyright - joint owners
Usage Statement
Record ID 8372
Record Created 2023-06-29
Record Appears in Organizations > Departments and Divisions > School of Medicine Clinical Sciences Departments and Divisions > Department of Medicine Divisions > Division of Hematology and Medical Oncology
Organizations > Schools > School of Medicine
OHSU Works > Events > Research Week
All Records

PDF

Statistics

from
to
Export
Download Full History